AR081268A1 - Derivados de nitrato de pioglitazona - Google Patents

Derivados de nitrato de pioglitazona

Info

Publication number
AR081268A1
AR081268A1 ARP110101869A ARP110101869A AR081268A1 AR 081268 A1 AR081268 A1 AR 081268A1 AR P110101869 A ARP110101869 A AR P110101869A AR P110101869 A ARP110101869 A AR P110101869A AR 081268 A1 AR081268 A1 AR 081268A1
Authority
AR
Argentina
Prior art keywords
ch2ch2o
piperazino
amino
pioglitazona
aminoethyl
Prior art date
Application number
ARP110101869A
Other languages
English (en)
Original Assignee
Cardiolynx Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiolynx Ag filed Critical Cardiolynx Ag
Publication of AR081268A1 publication Critical patent/AR081268A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describen éster nitrato y derivados de diazeniodiolato de pioglitazona y composición farmacéutica. Poseen propiedades valiosas en el tratamiento de las enfermedades vasculares y metabólicas, por ejemplo la diabetes tipo 2. Reivindicación 1: Un compuesto de la fórmula (1), (2) y (3) donde R1 es -(CH2CH2O)aX, -(CH2)bOX o -(CH2)cCH[(CH2)dOX]2; R2 es hidrógeno, metilo, etilo, -(CH2CH2O)aX, -(CH2)bOX o -CH2O(C=O)NH(CH2CH2O)aX; X es NO2 o N=(NO)-R3; R3 es di-(alquilo-C1-18)amino, di(2-aminoetil)amino, N-2-aminoetil-N-2-hidroxietil-amino, pirrolidino, piperidino, piperazino, 4-(alquilo C1-4)piperazino, 4-fenilpiperazino, 4-(2-piridil)piperazino o morfolino; a es 1,2 o 3; b se encuentra entre 1 y 6; c es 1 o 2; d se encuentra entre 1 y 4; y sus sales farmacéuticamente aceptables.
ARP110101869A 2010-06-02 2011-05-31 Derivados de nitrato de pioglitazona AR081268A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10164771 2010-06-02

Publications (1)

Publication Number Publication Date
AR081268A1 true AR081268A1 (es) 2012-07-18

Family

ID=42953758

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110101869A AR081268A1 (es) 2010-06-02 2011-05-31 Derivados de nitrato de pioglitazona

Country Status (8)

Country Link
US (1) US8703800B2 (es)
EP (1) EP2576545A1 (es)
JP (1) JP2013527216A (es)
AR (1) AR081268A1 (es)
AU (1) AU2011260325A1 (es)
CA (1) CA2801454A1 (es)
TW (1) TW201204355A (es)
WO (1) WO2011151362A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0618915A1 (en) * 1991-12-20 1994-10-12 The Upjohn Company A reduction method for substituted 5-methylene-thiazolidinediones
IT1311924B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1319201B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
US7163958B2 (en) 2002-07-03 2007-01-16 Nitromed Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
EP2194048A1 (en) 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases

Also Published As

Publication number Publication date
WO2011151362A1 (en) 2011-12-08
EP2576545A1 (en) 2013-04-10
US8703800B2 (en) 2014-04-22
JP2013527216A (ja) 2013-06-27
AU2011260325A1 (en) 2013-01-24
TW201204355A (en) 2012-02-01
CA2801454A1 (en) 2011-12-08
US20130072525A1 (en) 2013-03-21

Similar Documents

Publication Publication Date Title
PE20090288A1 (es) Derivados de quinoxalina como inhibidores de la pi3 quinasa
PE20142340A1 (es) Inhibidores de bromodominios
PE20141405A1 (es) Nuevos derivados de indolizina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
MX2011009034A (es) Formas de profarmaco de inhibidores de cinasa y su uso en la terapia.
AR059339A1 (es) Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene
ECSP088550A (es) Nuevos compuestos que son inhibidores de erk
HUP0401784A2 (hu) Heterobiciklikus szerkezetû virális polimeráz inhibitorok, eljárás az elõállításukra, köztitermékek és ezeket tartalmazó gyógyszerkészítmények
CO5700757A2 (es) Derivados de (3-oxo-3,4-dihidro-quinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad
NZ590355A (en) Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
PE20141120A1 (es) Compuestos heterociclicos
PE20151601A1 (es) Compuestos novedosos de pirimidina y piridina y su uso
AR078278A1 (es) Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro.
NZ607794A (en) N-acylsulfonamide apoptosis promoters
TR201904655T4 (tr) Piridilaminoasetik asit bileşiği.
CY1106130T1 (el) Παραγωγα 2-πυριδονης ως αναστολεις της ουδετepοφιλης ελαστασης
MY177250A (en) Novel nicotinamide derivative or salt thereof
PE20110063A1 (es) DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
TW200732336A (en) Alyphactic heterocyclic compounds
AR055613A1 (es) Formas cristalinas delta y epsilon de mesilato de imatinib
MX340060B (es) Nuevos derivados de 6-triazolopiridazina-sulfanil benzotiazol y bencimidazol, su proceso de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nuevo uso principalmente como inhibidores de met.
MX2007009372A (es) Nuevos compuestos ii derivados de 2-piridina como inhibidores de elastasa neutrofila.
DK1689721T3 (da) Aminopyrazolderivater som GSK-3-ihibitorer
GEP201606545B (en) 2-piperazin-1-yl-4h-1,3-benzo-thiazin-4-one derivatives and their use for treatment of mammalian infections
MX2009012380A (es) Compuestos de heteroarilamida pirimidona.
PE20091309A1 (es) Derivados de ciclohexilo como inhibidores de acetil coenzima a carboxilasa

Legal Events

Date Code Title Description
FB Suspension of granting procedure